Kathmere Capital Management, LLC
Position in TAK — Takeda Pharmaceutical Co Ltd
CIK 1794543
WAYNE, PA
Position in TAK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$217,959
-$77,101 QoQ
Shares Held
13,597
-14.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#204
of 376 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $1,705,003 across 6 Drug Manufacturers - Specialty & Generic names. TAK ranks #3 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,932 | $641,853 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,640 | $326,603 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
13,597 | $217,959 | |
| 4 | VTRS |
Viatris Inc
|
12,852 | $204,089 | |
| 5 | HLN |
Haleon plc
|
17,050 | $159,076 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
31,526 | $155,423 |
All Filings in TAK
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $217,959 | 13,597 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $295,060 | 15,932 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $172,175 | 11,044 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $178,124 | 12,167 | Shares | Sole | 2025-10-22 | |
| No filing history on record for this holder in this stock. | ||||||